Toxicological Assessments of Drug and Pathogens

Over the past decade, RBDI has assisted clients in the evaluation of specific aspects of drugs in support of new drug applications (NDAs), including toxicology, identification of target organs, mechanisms of action, enzyme inhibition, pharmacokinetics, and half-life studies.  Some of these include:

	Toxicological evaluation of a glutathione peroxidase-1 mimetic.
	Toxicological evaluation of novel pesticide compounds.
	Half-life of experimental drug for Type 2 diabetes.
	Evaluation of risks from exposure to viral pathogens in drinking water.